Remarkable bone formation following gefitinib for extensive lytic bone metastasis: A report of two cases
Gefitinib inhibits the epidermal growth factor receptor tyrosine kinase and improves survival in patients with non-small-cell lung cancer. We report 2 patients with extensive lytic bony metastasis in the spine and pelvis secondary to advanced pulmonary adenocarcinoma who were treated with gefitinib...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Hong Kong University Press
2016
|
| Subjects: |